Paloma Partners’s CME Group CME Stock Holding History

Paloma Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-900	Closed	-$190K	–	815
2023 Q4	$190K	Buy	+900	New	+$192K	0.01%	618
2023 Q1	–	Sell	-13,300	Closed	-$2.24M	–	781
2022 Q4	$2.24M	Buy	13,300 +13,200	+13,200%	+$2.29M	0.1%	192
2022 Q3	$18K	Buy	+100	New	+$19.8K	﹤0.01%	929
2018 Q1	–	Sell	-21,700	Closed	-$3.17M	–	1989
2017 Q4	$3.17M	Hold	21,700	–	–	0.04%	466
2017 Q3	$2.94M	Buy	21,700 +3,500	+19%	+$442K	0.04%	508
2017 Q2	$2.28M	Hold	18,200	–	–	0.03%	673
2017 Q1	$2.16M	Buy	18,200 +2,200	+14%	+$265K	0.03%	737
2016 Q4	$1.85M	Buy	16,000 +8,000	+100%	+$890K	0.02%	725
2016 Q3	$836K	Sell	8,000 -16,000	-67%	-$1.67M	0.01%	1143
2016 Q2	$2.34M	Buy	24,000 +8,000	+50%	+$756K	0.03%	639
2016 Q1	$1.54M	Buy	16,000 +8,000	+100%	+$728K	0.03%	614
2015 Q4	$725K	Hold	8,000	–	–	0.02%	824
2015 Q3	$742K	Buy	+8,000	New	+$760K	0.02%	816

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Paloma Partners's CME Position: Q3 2024 in Review

Paloma Partners sold out of CME Group (CME) in Q3 2024, closing a stake of 4,351 shares — an estimated $855K sold.

Paloma Partners first reported a position in CME in Q2 2013 and held it in 31 quarters. The position peaked at $23.3M in Q1 2016. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

Paloma Partners reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
Paloma Partners sold 4,351 CME Group shares in Q3 2024, an estimated $855K.
Paloma Partners first reported a position in CME Group in Q2 2013 and held it in 31 quarters.
Paloma Partners's CME Group position peaked at $23.3M in Q1 2016.
1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.